Advanced HCC with amplified mesenchymal epithelial transition factor receptor responds well to savolitinib: a case report.

Ning Yan, Zi Zhang,San Guo, Shu Shen, Xing Li

Frontiers in medicine(2023)

Cited 1|Views4
No score
Abstract
The present case report provides first-hand evidence that savolitinib may be beneficial for patients with advanced MET-amplified HCC and offers a promising treatment option.
More
Translated text
Key words
advanced hcc,receptor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined